Vitamin K2 plays an important role in healthy processes such as blood clotting, maintaining bone health and the prevention of atherosclerosis and cardiovascular disease
Liposomal vitamin K2
Liposoma offers white label liposomal vitamin K2 supplements. These supplements include high-quality vitamin K2, packed in a liposome, providing you with this vitamin’s numerous health effects. Vitamin K2 plays an important role in healthy processes such as blood clotting, maintaining bone health and the prevention of atherosclerosis and cardiovascular disease. Furthermore, recent research indicates a link between low vitamin K levels and poor disease outcome in patients with COVID-19. Our liposomal vitamin K2 supplements help maintain K2 levels at the right level. Supplements are available as capsules, liquids and a water-soluble powder. Moreover, we are open to discuss other tailored solutions. Our high-end liposomal K2 supplements are guaranteed by the academic qualifications of our team and its commitment to scientific excellence.
Vitamin K2 health benefits
Vitamin K2, also known as menaquinone, is known to be an important factor in blood clotting. Besides this, several studies reported vitamin K2 to be beneficial for bone health  and in the prevention of atherosclerosis and cardiovascular disease . In accordance with this, deficiencies in vitamin K2 are associated with the so-called “Calcium paradox”; the phenomenon in which calcium is depleted from bone tissue, and accumulating in vessel walls, which can result in the combination of osteoporosis and vascular calcification . Vitamin K2 is usually synthesized by bacteria. Small amounts can be directly consumed through animal products like meat, egg yolk and high fat dairy .
Why take vitamin K2 supplements?
As the body is unable to synthesize vitamin K, it needs to be taken up in adequate amounts through the diet. Vitamin K2 deficiency is frequently reported in patients with chronic diseases such as cardiovascular diseases, cancer, diabetes, arthritis and osteoporosis . Research has shown that in osteoporosis and cardiovascular diseases, patients can benefit from vitamin K2 supplementation . Vitamin K2 deficiency can also occur in babies, or in adults who take antibiotics for a prolonged time .
Moreover, not only patients, but also healthy people might benefit from vitamin K2 supplementation. Studies show that high vitamin K2 intake is associated with a reduced chance of atherosclerosis and cardiovascular disease . It was found that healthy postmenopausal women taking vitamin K2 supplements had increased bone health  and decreased arterial stiffness . Furthermore, studies suggest that supplementation with vitamin K2 contributes to reducing the risk of diabetes type 2 . Finally, markers for increased extrahepatic vitamin K2 levels were found in pre-pubertal children after supplementation , which is associated with a higher bone mineral content in children .
Vitamin K2 and COVID-19
A recent study indicates severely reduced extrahepatic levels of vitamin K in patients with COVID-19, which was also related to poor disease outcomes . Data from this study suggest a mechanism of depletion of extrahepatic vitamin K levels, induced by pneumonia in patients with severe COVID-19, which leads to thrombosis and accelerated elastic fibre damage . Although it has yet to be studied, it can be hypothesized that vitamin K supplementation and higher vitamin K levels in COVID-19 patients can contribute to improved health outcomes .
The benefits of liposomal vitamin K2
In addition to the numerous health effects of vitamin K2, it also has a very long half-life time of around 50 hours in which it is able to exert its functions . Vitamin K2 is a fat soluble vitamin . It is known that components that are fat-soluble often have a low oral bioavailability . Packing bioactives in liposomes is a promising tool to improve drug delivery, that could improve both the stability of the bioactive, and the uptake in the gastrointestinal tract . By using liposomes, the bioavailability of a fat-soluble component can be improved , which could make liposomal vitamin K2 supplementation more effective than regular vitamin K2 supplements.
“Our liposomal vitamins and other nutraceuticals are available as raw materials, capsules, liquids and many other tailored solutions. “
Liposoma Nutraceuticals; experts in liposomes
LIPOSOMA manufactures branded and white label liposomal supplements.
Our high-end liposomal nutraceuticals are guaranteed by the academic qualifications of our team and its commitment to scientific excellence.
Our liposome technology offers many advantages for nutritional supplement producers, the food sector and consumers. Our liposomal vitamins and other nutraceuticals are available as raw materials, capsules, liquids and many other tailored solutions.
Would you like to learn more? Give us a call at 0031 20 237 36 00
 Myneni, V. D., & Mezey, E. (2017). Regulation of bone remodeling by vitamin K2. Oral diseases, 23(8), 1021-1028.
 Schwalfenberg, G. K. (2017). Vitamins K1 and K2: the emerging group of vitamins required for human health. Journal of nutrition and metabolism, 2017.
 Flore, R., Ponziani, F. R., Di Rienzo, T. A., Zocco, M. A., Flex, A., Gerardino, L., … & Chierici, E. (2013). Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis. Eur Rev Med Pharmacol Sci, 17(18), 2433-2440.
4] Schurgers, L. J., & Vermeer, C. (2000). Determination of phylloquinone and menaquinones in food. Pathophysiology of Haemostasis and Thrombosis, 30(6), 298-307.
 Beulens, J. W., Bots, M. L., Atsma, F., Bartelink, M. L. E., Prokop, M., Geleijnse, J. M., … & Van Der Schouw, Y. T. (2009). High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis, 203(2), 489-493.
 Knapen, M. H. J., Drummen, N. E., Smit, E., Vermeer, C., & Theuwissen, E. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 24(9), 2499-2507.
 Knapen, M. H., Braam, L. A., Drummen, N. E., Bekers, O., Hoeks, A. P., & Vermeer, C. (2015). Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thrombosis and haemostasis, 113(05), 1135-1144.
 Li, Y., peng Chen, J., Duan, L., & Li, S. (2018). Effect of vitamin K2 on type 2 diabetes mellitus: A review. Diabetes Research and Clinical Practice, 136, 39-51.
 van Summeren, M. J., Braam, L. A., Lilien, M. R., Schurgers, L. J., Kuis, W., & Vermeer, C. (2009). The effect of menaquinone-7 (vitamin K 2) supplementation on osteocalcin carboxylation in healthy prepubertal children. British journal of nutrition, 102(8), 1171-1178.
 O’Connor, E., Mølgaard, C., Michaelsen, K. F., Jakobsen, J., Lamberg-Allardt, C. J., & Cashman, K. D. (2007). Serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, and its relationship to bone health indices in Danish girls. British journal of nutrition, 97(4), 661-666.
 Dofferhoff, A. S., Piscaer, I., Schurgers, L. J., Visser, M. P., van den Ouweland, J. M., de Jong, P. A., … & Maassen, C. (2020). Reduced vitamin K status as a potentially modifiable risk factor of severe COVID-19. Clinical Infectious Diseases.
 Fricker, G., Kromp, T., Wendel, A., Blume, A., Zirkel, J., Rebmann, H., … & Müller-Goymann, C. (2010). Phospholipids and lipid-based formulations in oral drug delivery. Pharmaceutical research, 27(8), 1469-1486.
 Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., … & Nejati-Koshki, K. (2013). Liposome: classification, preparation, and applications. Nanoscale research letters, 8(1), 102.